MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol

Despite progress in the treatment of head and neck squamous cell carcinoma (HNSCC) in recent decades, including new surgical techniques, radiotherapy advances and chemotherapy schedules, the prognosis for the affected patients has not improved at the same pace, and still, most HNSCC patients are dia...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Arantes, Lidia Maria Rebolho Batista, Laus, Ana Carolina, Melendez, Matias Eliseo, de Carvalho, Ana Carolina, Sorroche, Bruna Pereira, De Marchi, Pedro Rafael Martins, Evangelista, Adriane Feijó, Scapulatempo-Neto, Cristovam, de Souza Viana, Luciano, Carvalho, André Lopes
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5354780/
https://ncbi.nlm.nih.gov/pubmed/28039483
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.14253
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados